{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T03:55:36Z","timestamp":1778644536309,"version":"3.51.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T00:00:00Z","timestamp":1598227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T00:00:00Z","timestamp":1598227200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Keimyung University Dongsan Medical Center"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The aim of this study was to evaluate the correlation between changes in the macular capillary network and macular edema (ME) recurrence with branch retinal vein occlusion (BRVO) using swept-source optical coherence tomography angiography (SS-OCTA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We reviewed the data for 43 patients with treatment-na\u00efve ME associated with BRVO. Patients who received intravitreal bevacizumab injection were divided into two groups based on ME recurrence at 6\u2009months after edema resolution. The perifoveal capillary morphology and the macular capillary vessel density (VD) were retrospectively analyzed using\n                      <jats:italic>en face<\/jats:italic>\n                      SS-OCTA after ME resolution.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The perifoveal capillary ring loss in the superficial capillary plexus (SCP) and deep capillary plexus (DCP) was more common in the ME recurrence group (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200922) than in the no ME recurrence group (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.047 and\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.002). Relative to the findings in the no ME recurrence groups, the destruction of the perifoveal capillary ring was more severe in the DCP (30.0\u00b0 vs 87.3\u00b0,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001) than in the SCP (17.3\u00b0 vs 69.5\u00b0,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.006) in the ME recurrence group. The hemi-VD disparity between the affected and the unaffected areas in the SCP and DCP showed significant differences (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.031 and\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.017), while macular VD showed no differences between the groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Destruction of the perifoveal capillary ring and hemi-VD disparity could be related to ME recurrence in BRVO. Therefore, these factors may be helpful in predicting ME recurrence.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12886-020-01611-w","type":"journal-article","created":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T07:03:02Z","timestamp":1598252582000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Correlation between macular edema recurrence and macular capillary network destruction in branch retinal vein occlusion"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9501-9892","authenticated-orcid":false,"given":"Ji Hye","family":"Jang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1615-6651","authenticated-orcid":false,"given":"Yu Cheol","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Pil","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,24]]},"reference":[{"issue":"11","key":"1611_CR1","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/BF00164677","volume":"233","author":"RM Silva","year":"1995","unstructured":"Silva RM, Faria de Abreu JR, Cunha-Vaz JG. Blood-retina barrier in acute retinal branch vein occlusion. Graefes Arch Clin Exp Ophthalmol. 1995;233(11):721\u20136.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"2","key":"1611_CR2","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1080\/02713680701851902","volume":"33","author":"J Rehak","year":"2008","unstructured":"Rehak J, Rehak M. Branch retinal vein occlusion: pathogenesis, visual prognosis, and treatment modalities. Curr Eye Res. 2008;33(2):111\u201331.","journal-title":"Curr Eye Res"},{"issue":"6","key":"1611_CR3","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.ophtha.2010.01.058","volume":"117","author":"SL Rogers","year":"2010","unstructured":"Rogers SL, McIntosh RL, Lim L, Mitchell P, Cheung N, Kowalski JW, et al. Natural history of branch retinal vein occlusion: an evidence-based systematic review. Ophthalmology. 2010;117(6):1094\u2013101.","journal-title":"Ophthalmology."},{"issue":"11","key":"1611_CR4","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1016\/S0161-6420(96)30420-X","volume":"103","author":"MJ Tolentino","year":"1996","unstructured":"Tolentino MJ, Miller JW, Gragoudas ES, Jakobiec FA, Flynn E, Chatzstefanou K, et al. Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. Ophthalmology. 1996;103(11):1820\u20138.","journal-title":"Ophthalmology."},{"issue":"2","key":"1611_CR5","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.ajo.2005.03.003","volume":"140","author":"H Noma","year":"2005","unstructured":"Noma H, Funatsu H, Yamasaki M, Tsukamoto H, Minura T, Sone T, et al. Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6. Am J Ophthalmol. 2005;140(2):256\u201361.","journal-title":"Am J Ophthalmol"},{"key":"1611_CR6","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.preteyeres.2017.10.006","volume":"63","author":"A Daruich","year":"2018","unstructured":"Daruich A, Matet A, Moulin A, Kowalczuk L, Nicolas M, Sellam A, et al. Mechanisms of macular edema: beyond the surface. Prog Retina Eye Res. 2018;63:20\u201368.","journal-title":"Prog Retina Eye Res"},{"issue":"4","key":"1611_CR7","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1136\/bjo.2008.141085","volume":"93","author":"F Prager","year":"2009","unstructured":"Prager F, Michels S, Kriechbaum K, Georgopoulos M, Funk M, Geitzenauer W, et al. Intravitreal bevacizumab (avastin) for macular edema secondary to retinal vein occlusion: 12-month results of a prospective clinical trial. Br J Ophthalmol. 2009;93(4):452\u20136.","journal-title":"Br J Ophthalmol"},{"issue":"12","key":"1611_CR8","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1016\/j.ophtha.2017.06.027","volume":"124","author":"R Tadayoni","year":"2017","unstructured":"Tadayoni R, Waldstein SM, Boscia F, Gerding H, Gekkieva M, Barnes E, et al. Sustained benefits of ranibizumab with or without laser in branch retinal vein occlusion: 24-month results of the BRIGHTER study. Ophthalmology. 2017;124(12):1778\u201387.","journal-title":"Ophthalmology."},{"issue":"2","key":"1611_CR9","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1159\/000487547","volume":"240","author":"YH Yoon","year":"2018","unstructured":"Yoon YH, Kim JW, Lee JY, Kim IT, Kang W, Yu HG, et al. Dexamethasone intravitreal implant for early treatment and retreatment of macular edema related to branch retinal vein occlusion: the multicenter COBALT study. Ophthalmologica. 2018;240(2):81\u20139.","journal-title":"Ophthalmologica."},{"issue":"2","key":"1611_CR10","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3341\/kjo.2017.31.2.95","volume":"31","author":"SJ Yoo","year":"2017","unstructured":"Yoo SJ, Kim JH, Lee TG, Kim JW, Cho SW, Han JI. Natural short-term course of recurrent macular edema following intravitreal bevacizumab therapy in branch retinal vein occlusion. Korean J Ophthalmol. 2017;31(2):95\u2013101.","journal-title":"Korean J Ophthalmol"},{"issue":"10","key":"1611_CR11","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1097\/IAE.0000000000001158","volume":"36","author":"RF Spaide","year":"2016","unstructured":"Spaide RF. Retinal vascular cystoid macular edema: review and new theory. Retina. 2016;36(10):1823\u201342.","journal-title":"Retina."},{"issue":"4","key":"1611_CR12","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1167\/iovs.17-21447","volume":"58","author":"K Tsuboi","year":"2017","unstructured":"Tsuboi K, Ishida Y, Kamei M. Gap in capillary perfusion on optical coherence tomography angiography associated with persistent macular edema in branch retinal vein occlusion. Invest Ophthalmol Vis Sci. 2017;58(4):2038\u201343.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"1611_CR13","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1097\/00006982-200306000-00009","volume":"23","author":"RF Spaide","year":"2003","unstructured":"Spaide RF, Lee JK, Klancnik JK Jr, Gross NE. Optical coherence tomography of branch retinal vein occlusion. Retina. 2003;23(3):343\u20137.","journal-title":"Retina."},{"issue":"11","key":"1611_CR14","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1007\/s00417-010-1419-5","volume":"248","author":"AE Hoeh","year":"2010","unstructured":"Hoeh AE, Ruppenstein M, Ach T, Dithmar S. OCT patterns of macular edema and response to bevacizumab therapy in retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol. 2010;248(11):1567\u201372.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"6","key":"1611_CR15","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1001\/jamaophthalmol.2015.0668","volume":"133","author":"A Nagiel","year":"2015","unstructured":"Nagiel A, Sadda SR, Sarraf D. A promising future for optical coherence tomography angiography. JAMA Ophthalmol. 2015;133(6):629\u201330.","journal-title":"JAMA Ophthalmol"},{"key":"1611_CR16","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.preteyeres.2017.07.002","volume":"60","author":"AH Kashani","year":"2017","unstructured":"Kashani AH, Chen CL, Gahm JK, Zheng F, Richter GM, Rosenfeld PJ, et al. Optical coherence tomography angiography: a comprehensive review of current methods and clinical applications. Prog Retin Eye Res. 2017;60:66\u2013100.","journal-title":"Prog Retin Eye Res"},{"issue":"3","key":"1611_CR17","doi-asserted-by":"publisher","first-page":"315","DOI":"10.4103\/jovr.jovr_264_17","volume":"13","author":"G Tsai","year":"2018","unstructured":"Tsai G, Banaee T, Conti FF, Singh RP. Optical coherence tomography angiography in eyes with retinal vein occlusion. J Ophthalmic Vis Res. 2018;13(3):315\u201332.","journal-title":"J Ophthalmic Vis Res"},{"issue":"4","key":"1611_CR18","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S0002-9394(14)70001-7","volume":"117","author":"SS Hayreh","year":"1994","unstructured":"Hayreh SS, Zimmerman MB, Podhajsky P. Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics. Am J Ophthalmol. 1994;117(4):429\u201341.","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"1611_CR19","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.ophtha.2010.06.034","volume":"118","author":"IU Scott","year":"2011","unstructured":"Scott IU, VanVeldhuisen PC, Oden NL, Ip MS, Blodi BA, Hartnett ME, et al. Baseline predictors of visual acuity and retinal thickness outcomes in patients with branch retinal vein occlusion: standard care versus corticosteriod for retinal vein occlusion study report 10. Ophthalmology. 2011;118(2):345\u201352.","journal-title":"Ophthalmology."},{"issue":"1","key":"1611_CR20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1001\/jamaophthalmol.2013.5515","volume":"132","author":"SS Hayreh","year":"2014","unstructured":"Hayreh SS, Zimmerman MB. Branch retinal vein occlusion: natural history of visual outcome. JAMA Ophthalmol. 2014;132(1):13\u201322.","journal-title":"JAMA Ophthalmol."},{"issue":"4","key":"1611_CR21","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.ajo.2013.05.033","volume":"156","author":"DA Sim","year":"2013","unstructured":"Sim DA, Keane PA, Zarranz-Ventura J, Bunce CV, Fruttiger M, Patel PJ, et al. Predictive factors for the progression of diabetic macular ischemia. Am J Ophthalmol. 2013;156(4):684\u201392.","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"1611_CR22","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1001\/archopht.1992.01080220089028","volume":"110","author":"D Finkelstein","year":"1992","unstructured":"Finkelstein D. Ischemic macular edema. Recognition and favorable natural history in branch vein occlusion. Arch Ophthalmol. 1992;110(10):1427\u201334.","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"1611_CR23","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1167\/iovs.16-21208","volume":"58","author":"T Wakabayashi","year":"2017","unstructured":"Wakabayashi T, Sato T, Hara-Ueno C, et al. Retinal microvasculature and visual acuity in eyes with branch retinal vein occlusion: imaging analysis by optical coherence tomography angiography. Invest Ophthalmol Vis Sci. 2017;58(4):2087\u201394.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1611_CR24","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.preteyeres.2013.01.005","volume":"35","author":"JM Provis","year":"2013","unstructured":"Provis JM, Dubis AM, Maddess T, Carroll J. Adaptation of the central retina for high acuity vision: cones, the fovea and the avascular zone. Prog Retin Eye Res. 2013;35:63\u201381.","journal-title":"Prog Retin Eye Res"},{"issue":"9","key":"1611_CR25","doi-asserted-by":"publisher","first-page":"OCT211","DOI":"10.1167\/iovs.15-18793","volume":"57","author":"F Coscas","year":"2016","unstructured":"Coscas F, Sellam A, Glacet-Bernard A, et al. Normative data for vascular density in superficial and deep capillary plexuses of healthy adults assessed by optical coherence tomography angiography. Invest Ophthalmol Vis Sci. 2016;57(9):OCT211\u201323.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"1611_CR26","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/BF00156415","volume":"19","author":"MB Parodi","year":"1995","unstructured":"Parodi MB, Visintin F, Della Rupe P, Ravalico G. Foveal avascular zone in macular branch retinal vein occlusion. Int Ophthalmol. 1995;19(1):25\u20138.","journal-title":"Int Ophthalmol"},{"issue":"3","key":"1611_CR27","doi-asserted-by":"publisher","first-page":"260","DOI":"10.4103\/jovr.jovr_173_17","volume":"13","author":"KG Falavarjani","year":"2018","unstructured":"Falavarjani KG, Shenazandi H, Naseri D, Anvari P, Kazemi P, Aghamohammadi F, et al. Foveal avascular zone and vessel density in healthy subjects: an optical coherence tomography angiography study. J Ophthalmic Vis Res. 2018;13(3):260\u20135.","journal-title":"J Ophthalmic Vis Res"},{"issue":"8","key":"1611_CR28","doi-asserted-by":"publisher","first-page":"3907","DOI":"10.1167\/iovs.16-19570","volume":"57","author":"M Al-Sheikh","year":"2016","unstructured":"Al-Sheikh M, Akil H, Pfau M, Sadda SR. Swept-source OCT angiography imaging of the foveal avascular zone and macular capillary network density in diabetic retinopathy. Invest Ophthalmol Vis Sci. 2016;57(8):3907\u201313.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"1611_CR29","doi-asserted-by":"publisher","first-page":"OCT486","DOI":"10.1167\/iovs.15-18907","volume":"57","author":"M Adhi","year":"2016","unstructured":"Adhi M, Filho MA, Louzada RN, Kuehlewein L, Talisa E, Baumal CR, et al. Retinal capillary network and foveal avascular zone in eyes with vein occlusion and fellow eyes analyzed with optical coherence tomography angiography. Invest Ophthalmol Vis Sci. 2016;57(9):OCT486\u201394.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"1611_CR30","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1001\/jamaophthalmol.2014.3616","volume":"133","author":"RF Spaide","year":"2015","unstructured":"Spaide RF, Klancnik JM Jr, Cooney MJ. Retinal vascular layers imaged by fluorescein angiography and optical coherence tomography angiography. JAMA Ophthalmol. 2015;133(1):45\u201350.","journal-title":"JAMA Ophthalmol."},{"issue":"11","key":"1611_CR31","doi-asserted-by":"publisher","first-page":"e175","DOI":"10.3928\/23258160-20181101-15","volume":"49","author":"T Mochi","year":"2018","unstructured":"Mochi T, Anegondi N, Girish M, Jayadev C, Sinha RA. Quantitative comparison between optical coherence tomography angiography and fundus fluorescein angiography images: effect of vessel enhancement. Ophthalmic Surg Lasers Imaging Retina. 2018;49(11):e175\u201381.","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"3","key":"1611_CR32","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/ICU.0000000000000045","volume":"25","author":"E Rahimy","year":"2014","unstructured":"Rahimy E, Sarraf D. Paracentral acute middle maculopathy spectral-domain optical coherence tomography feature of deep capillary ischemia. Curr Opin Ophthalmol. 2014;25(3):207\u201312.","journal-title":"Curr Opin Ophthalmol"},{"issue":"3","key":"1611_CR33","doi-asserted-by":"publisher","first-page":"H1696","DOI":"10.1152\/ajpheart.00221.2007","volume":"293","author":"G Birol","year":"2007","unstructured":"Birol G, Wang S, Budzynski E, Wangsa-Wirawan ND, Linsenmeier RA. Oxygen distribution and consumption in the macaque retina. Am J Physiol Heart Circ Physiol. 2007;293(3):H1696\u2013704.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"1611_CR34","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1136\/bjophthalmol-2017-311499","volume":"103","author":"T Hasegawa","year":"2019","unstructured":"Hasegawa T, Murakawa S, Maruko I, Kogure Katakura A, Iida T. Correlation between reduction in macular vessel density and frequency of intravitreal ranibizumab for macular edema in eyes with branch retinal vein occlusion. Br J Ophthalmol. 2019;103(1):72\u20137.","journal-title":"Br J Ophthalmol"},{"key":"1611_CR35","first-page":"39","volume":"7","author":"S Sakimoto","year":"2013","unstructured":"Sakimoto S, Kamei M, Suzuki M, Yano S, Matsumura N, Sakaguchi H, et al. Relationship between grades of macular perfusion and foveal thickness in branch retinal vein occlusion. Clin Ophthalmol. 2013;7:39\u201345.","journal-title":"Clin Ophthalmol"},{"issue":"10","key":"1611_CR36","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1097\/IAE.0000000000002264","volume":"39","author":"L Yeung","year":"2019","unstructured":"Yeung L, Wu WC, Chuang LH, Wang NK, Lai CC. Novel optical coherence tomography angiography biomarker in branch retinal vein occlusion macular edema. Retina. 2019;39(10):1906\u201316.","journal-title":"Retina."}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-020-01611-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-020-01611-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-020-01611-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T19:36:42Z","timestamp":1629747402000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-020-01611-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,24]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1611"],"URL":"https:\/\/doi.org\/10.1186\/s12886-020-01611-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.15437\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.15437\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.15437\/v3","asserted-by":"object"}]},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,24]]},"assertion":[{"value":"22 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This study was approved by the Keimyung University Institutional Review Board (IRB no. 2018\u201309-039).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Instead of obtaining consent for publication from the subject, identification data such as age and gender have been anonymized.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"J.H.J received payment for lectures from Bayer, Novartis outside the submitted work. Y.C.K reports honorarium from Allergan, Bayer, Novartis and Santan, and a research grant from Bayer, outside the submitted work. J.P.S received nonfinancial supports.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"341"}}